DNA Sequencing Market By Type (Consumable, Instrument, and Service), By Applications (Biomarkers and Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Forensics, and Other Applications), By Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single Molecule Real Time Sequencing, Chain Termination Sequencing, and Nanopore Sequencing), By End User (Academic & Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, and Hospitals & Clinics), Industry Trends, Estimation & Forecast, 2023-2030

Market Overview

DNA sequencing is the process of determining the sequence of nucleotides within a DNA molecule. It includes any method that is used to determine the order of the four bases adenine, guanine, cytosine, and thymine.DNA sequences have become essential for basic biological research, and in numerous applied fields such as biotechnology, forensic biology, medical diagnosis, virology and biological systematics.DNA sequences diagnose different diseases such as various cancer type, characterize antibody repertoire, and can be used to guide patient treatment.DNA sequencing is used to determine the sequence of individual genes, larger genetic regions, full chromosomes, or entire genomes of any organism.

DNA Sequencing market is estimated to reach $61.2 billion by 2030; growing at a CAGR of 18.5% till 2030

Market Dynamics

Technological advancements in DNA sequencing is boosting the global DNA Sequencing market. The companies are advancing DNA sequencing technology. For instance, Longas Technologies Pty Ltd, a developer of Next Generation Sequencing (NGS) technologies, has introduced its Morphoseq technology. Morphoseq is a disruptive technology designed to improve the performance of industry-standard NGS platforms by increasing effective read lengths, with benefits in accuracy and cost-efficiency. Moreover, Pacific Biosciences of California, Inc., the leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, has enhanced its Sequel System, by including a new version (6.0) of its software, new SMRT Cell (1M v3)and new consumable reagents (3.0). Sequel System 6.0 improve the performance and affordability of Single Molecule, Real-Time (SMRT) Sequencing provide individual long reads with greater than 99% accuracy, increasing the throughput up to 50 Gb per SMRT Cell. Further Surge in applications of DNA sequencing, Increasing partnerships & collaborations are key driving factors of the market. However, Lack of standardization in DNA sequencing protocols, especially NGS-based diagnostics, might hamper the market growth. Lucrative opportunities in emerging markets would provide lucrative opportunities for the market in the coming years.

Market Segmentation

The global DNA Sequencing market is mainly classified based on Type, Applications, Technology, End User. Type is further segmented into Consumable, Instrument, Service. Consumable is dominating the global DNA Sequencing market by type. The consumables are used in-sequencing step to ensure that the sample DNA subjected to sequencing is processed accurately to generate the desirable nucleotide sequence. Pre-sequencing products & services include sample preparation products such as DNA fragmentation, end-repair A-tailing, size selection, library preparation, target enrichment, and quality control products. The DNA sequencing consumables market is expected to grow in the coming years due to the advent of novel pre-sequencing products and kits for executing DNA fragmentation, target enrichment, size selection, and others. For instance, NEBNext Direct product line from NEB is anew technology that improves target enrichment for NGS. This unique hybridization-based technology permits high sensitivity and precision, which could be formally achieved using multiplex PCR-based approaches. Further, the global DNA Sequencing market is segmented into By Applications, the market is divided into Biomarkers and Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Forensics, Other Applications. By Technology the market is further divided into Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single-Molecule Real-Time Sequencing, Chain Termination Sequencing, Nanopore Sequencing. By End User, the global DNA Sequencing market is divided as Academic & Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, Hospitals & Clinics.

Regional Analysis

Based on geography, the global DNA Sequencing market is divided into North America, Europe, Asia-Pacific, South America, and Middle East & Africa. North America is dominating the global DNA Sequencing market. North America is further divided in the U.S., Canada, and Mexico. The regulatory approval for the product is boosting North America DNA Sequencing market. For instance, Verogen Inc. has received approval from the United States Federal Bureau of Investigation for the company’s next-gen forensic DNA technology for use by forensic laboratories generating DNA profiles for upload to the National DNA Index System (NDIS). Verogen’sMiSeqFGx Forensic Genomics System is the first NDIS approved solution for genomic DNA analysis that harnesses “Next Generation Sequencing” (NGS) technology to dramatically increase profiling efficiency and data recovery from biological evidence. The global DNA Sequencing market is further segmented into Europe consists of the UK, Germany, France, Italy, and Rest of Europe. Asia-Pacific is segmented into India, China, Japan, South Korea, and Rest of Asia-Pacific. The South America region includes Brazil, Argentina, and the Rest of South America, while the Middle East & Africa is categorized into GCC Countries, Egypt, South Africa, and Rest of Middle East & Africa.

Key Players

Key players operating in the DNA Sequencing industry include Abbott Laboratories, Agilent Technologies, Inc., Danaher Corporation (Beckman Coulter, Inc), F. Hoffmann-La Roche Ltd, Illumina, Inc., LI-COR Biosciences, Inc., Pacific Biosciences of California, Inc., Siemens Aktiengesellschaft, Thermo Fisher Scientific Inc., ZS Genetics, Inc.

The technological advancement of companies for DNA Sequencing is boosting the global DNA Sequencing market. For instance, on November 21, 2019, Universal Sequencing Technology Corporation (‘UST’), a developer of Next Generation Sequencing (NGS) technologies, has introduced its TELL-Seq technology for linked, long-read DNA sequencing applications. These kits allow to conveniently and effectively turn a short-read DNA sequencer into a long-read DNA sequencer. The increasing partnership between companies to Deliver Sequencing-Based tests is boosting the global DNA Sequencing market. For instance, Illumina, Inc. and QIAGEN N.V. have signed 15-year partnership intended to broaden the availability and use of NGS-based in-vitro diagnostic (IVD) kits, including companion diagnostics, for patient management. This Partnership is to accelerate the adoption of next-generation sequencing (NGS) in clinical decision-making.

DNA Sequencing Market Key Segments

By Type
• Consumable
• Instrument
• Service

By Applications
• Biomarkers and Cancer
• Diagnostics
• Reproductive Health
• Personalized Medicine
• Forensics
• Other Applications

By Technology
• Sequencing by Synthesis
• Ion Semiconductor Sequencing
• Sequencing by Ligation
• Pyrosequencing
• Single-Molecule Real-Time Sequencing
• Chain Termination Sequencing
• Nanopore Sequencing

By End User
• Academic & Government Research Institutes
• Pharmaceutical Companies
• Biotechnology Companies
• Hospitals & Clinics

By Geography

• North America
o The U.S.
o Canada
o Mexico
• Europe
o U.K
o Germany
o France
o Italy
o Rest of Europe
• Asia Pacific
o India
o China
o Japan
o South Korea
o Rest of Asia Pacific
• South America
o Brazil
o Argentina
o Rest of South America
• Middle East & Africa
o GCC Countries
o Egypt
o South Africa
o Rest of Middle East & Africa

Key Global DNA Sequencing Industry Players

• Abbott Laboratories
• Agilent Technologies, Inc.
• Danaher Corporation (Beckman Coulter, Inc)
• F. Hoffmann-La Roche Ltd
• Illumina, Inc.
• LI-COR Biosciences, Inc.
• Pacific Biosciences of California, Inc.
• Siemens Aktiengesellschaft
• Thermo Fisher Scientific Inc.
• ZS Genetics, Inc.

Table of Content

1. Market Introduction
1.1. Executive Summary
1.2. Market Definition
1.3. Market Scope

2. Research Methodology
2.1. Primary Research
2.2. Research Methodology
2.3. Assumptions & Exclusions
2.4. Secondary data sources

3. DNA Sequencing Market Overview
3.1. Report Segmentation & Scope
3.2. Key Market Trend
3.3. Drivers
3.3.1. Technological advancements in DNA sequencing
3.3.2. Surge in applications of DNA sequencing
3.3.3. Increasing partnerships & collaborations
3.4. Restraints
3.4.1. Lack of standardization in DNA sequencing protocols, especially NGS-based diagnostics
3.5. Opportunity
3.5.1. Lucrative opportunities in emerging markets
3.6. Porter’s Five Forces Analysis
3.6.1. Porter’s Five Forces Analysis
3.7. Market Share Analysis

4. Type Overview
4.1. Introduction
4.1.1. Market Size & Forecast
4.2. Consumable
4.2.1. Market Size & Forecast
4.3. Instrument
4.3.1. Market Size & Forecast
4.4. Service
4.4.1. Market Size & Forecast

5. Applications Overview
5.1. Introduction
5.1.1. Market Size & Forecast
5.2. Biomarkers and Cancer
5.2.1. Market Size & Forecast
5.3. Diagnostics
5.3.1. Market Size & Forecast
5.4. Reproductive Health
5.4.1. Market Size & Forecast
5.5. Personalized Medicine
5.5.1. Market Size & Forecast
5.6. Forensics
5.6.1. Market Size & Forecast
5.7. Other Applications
5.7.1. Market Size & Forecast

6. Technology Overview
6.1. Introduction
6.1.1. Market Size & Forecast
6.2. Sequencing by Synthesis
6.2.1. Market Size & Forecast
6.3. Ion Semiconductor Sequencing
6.3.1. Market Size & Forecast
6.4. Sequencing by Ligation
6.4.1. Market Size & Forecast
6.5. Pyrosequencing
6.5.1. Market Size & Forecast
6.6. Single-Molecule Real-Time Sequencing
6.6.1. Market Size & Forecast
6.7. Chain Termination Sequencing
6.7.1. Market Size & Forecast
6.8. Nanopore Sequencing
6.8.1. Market Size & Forecast

7. End User Overview
7.1. Introduction
7.1.1. Market Size & Forecast
7.2. Academic & Government Research Institutes
7.2.1. Market Size & Forecast
7.3. Pharmaceutical Companies
7.3.1. Market Size & Forecast
7.4. Biotechnology Companies
7.4.1. Market Size & Forecast
7.5. Hospitals & Clinics
7.5.1. Market Size & Forecast

8. DNA Sequencing Market Regional Overview
8.1. Introduction
8.1.1. Market Size & Forecast
8.2. North America DNA Sequencing Market
8.2.1. North America Market Size & Forecast, By Country
8.2.2. North America Market Size & Forecast, By Type
8.2.3. North America Market Size & Forecast, By Applications
8.2.4. North America Market Size & Forecast, By Technology
8.2.5. North America Market Size & Forecast, By End User
8.2.6. The U.S.
8.2.6.1. Market Size and Forecast
8.2.7. Canada
8.2.7.1. Market Size and Forecast
8.2.8. Mexico
8.2.8.1. Market Size and Forecast
8.3. Europe DNA Sequencing Market
8.3.1. Europe Market Size & Forecast, By Country
8.3.2. Europe Market Size & Forecast, By Type
8.3.3. Europe Market Size & Forecast, By Applications
8.3.4. Europe Market Size & Forecast, By Technology
8.3.5. Europe Market Size & Forecast, By End User
8.3.6. Germany
8.3.6.1. Market Size and Forecast
8.3.7. France
8.3.7.1. Market Size and Forecast
8.3.8. UK
8.3.8.1. Market Size and Forecast
8.3.9. Italy
8.3.9.1. Market Size and Forecast
8.3.10. Spain
8.3.10.1. Market Size and Forecast
8.3.11. Rest of Europe
8.3.11.1. Market Size and Forecast
8.4. Asia-Pacific DNA Sequencing Market
8.4.1. Asia-Pacific Market Size & Forecast, By Country
8.4.2. Asia-Pacific Market Size & Forecast, By Type
8.4.3. Asia-Pacific Market Size & Forecast, By Applications
8.4.4. Asia-Pacific Market Size & Forecast, By Technology
8.4.5. Asia-Pacific Market Size & Forecast, By End User
8.4.6. Japan
8.4.6.1. Market Size and Forecast
8.4.7. China
8.4.7.1. Market Size and Forecast
8.4.8. Australia
8.4.8.1. Market Size and Forecast
8.4.9. India
8.4.9.1. Market Size and Forecast
8.4.10. South Korea
8.4.10.1. Market Size and Forecast
8.4.11. Rest of Asia-Pacific
8.4.11.1. Market Size and Forecast
8.5. South America DNA Sequencing Market
8.5.1. South America Market Size & Forecast, By Country
8.5.2. South America Market Size & Forecast, By Type
8.5.3. South America Market Size & Forecast, By Applications
8.5.4. South America Market Size & Forecast, By Technology
8.5.5. South America Market Size & Forecast, By End User
8.5.6. Brazil
8.5.6.1. Market Size and Forecast
8.5.7. Argentina
8.5.7.1. Market Size and Forecast
8.5.8. Rest of South America
8.5.8.1. Market Size and Forecast
8.6. Middle East & Africa DNA Sequencing Market
8.6.1. Middle East & Africa Market Size & Forecast, By Country
8.6.2. Middle East & Africa Market Size & Forecast, By Type
8.6.3. Middle East & Africa Market Size & Forecast, By Applications
8.6.4. Middle East & Africa Market Size & Forecast, By Technology
8.6.5. Middle East & Africa Market Size & Forecast, By End User
8.6.6. GCC Countries
8.6.6.1. Market Size and Forecast
8.6.7. Egypt
8.6.7.1. Market Size and Forecast
8.6.8. South Africa
8.6.8.1. Market Size and Forecast
8.6.9. Rest of Middle East & Africa
8.6.9.1. Market Size and Forecast

9. Company Profile
9.1. Abbott Laboratories
9.1.1. Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
9.1.2. Abbott Laboratories Product Category, Application, and Specification
9.1.3. Abbott Laboratories Financial Performance (2016-2018)
9.1.4. Main Business/Business Overview
9.2. Agilent Technologies, Inc.
9.3. Danaher Corporation (Beckman Coulter, Inc)
9.4. F. Hoffmann-La Roche Ltd
9.5. Illumina, Inc.
9.6. LI-COR Biosciences, Inc.
9.7. Pacific Biosciences of California, Inc.
9.8. Siemens Aktiengesellschaft
9.9. Thermo Fisher Scientific Inc.
9.10. ZS Genetics, Inc.